factors established in the rat Thy 1 model of mesangiolysis and Growth factor expression in a murine model of cryoglobulirepairs to a murine model of progressive glomerulonephritis nemia.
Cryoglobulinemia is a systemic disease with a wide stromal lymphopoietin (TSLP) transgenic mice develop mixed spectrum of manifestations [1, 2] . Up to 55% of patients cryoglobulinemia and a membranoproliferative glomerulonephritis (MPGN). Here we describe the renal expression of with mixed cryoglobulinemia develop renal involvement isoforms of PDGF and TGF-␤ in relation to changes in extra- [1] [2] [3] [4] . The typical renal manifestation of mixed cryoglocellular matrix (ECM) components and markers of cell proliferbulinemia is a membranoproliferative glomerulonephriation and activation in this model. be present in cryoglobulinemic glomerulonephritis [5] [6] [7] . [8, 9] . PDGF, which can be released from activated plate- is involved in ECM expansion [10] [11] [12] [13] [14] [15] . TGF-␤ promotes These findings extend the paradigms covering these growth glomerular injury through the accumulation of ECM, leading to glomerulosclerosis. Increased synthesis of normal glomerular ECM components (type IV collagen, Thymic stromal lymphopoietin (TSLP) is a cytokine that was isolated from conditioned medium of a thymic [21] . Renal involvement in TSLP transan indirect immunoperoxidase technique as previously genic mice is characterized by monocyte/macrophage indescribed [21, 23] . Sections were deparaffinized in xyfiltration, marked ECM expansion, increased glomerular lene, rehydrated in graded ethanol and then incubated cellularity, and prominent accumulation of subendothein 3% hydrogen peroxide for five minutes to block enlial and mesangial electron-dense deposits closely resemdogenous peroxidase. Endogenous biotin was blocked bling the morphological features of human MPGN [21] .
tis (MPGN) characterized by deposits of immune com-
using the Avidin-Biotin blocking Kit (Vector LaboraThis new model of a membranoproliferative type of glotories, Burlingame, CA, USA). Antigen retrieval was merular injury gave us the opportunity to describe the performed by heat treatment. Sections were sequentially sequence of cellular events involving the growth factors incubated with 10% normal serum, the primary antibody mentioned above. We further assessed the expression of diluted in phosphate-buffered saline (PBS) containing alpha-smooth muscle actin (␣SMA; a marker of activated 1% bovine serum albumin for one hour, followed by the mesangial cells), and accumulations of several compobiotinylated secondary antibody (Vector Laboratories), nents of the ECM, and correlated these with the expresand the avidin-biotin-horseradish peroxidase (HRP) sion patterns of PDGF and TGF-␤1. We also evaluated complex (Vector). The immunoreaction was visualized monocyte/macrophage expression of the growth factors by 3,3Ј-diaminobenzidine (DAB; Sigma, St. Louis, MO, PDGF-B chain and TGF-␤1, as well as PDGF ␤-receptor USA) with nickel chloride enhancement, resulting in a (PDGF-␤-R) by combined immunohistochemistry and black color product. After methyl green counterstaining, in situ hybridization.
the slides were dehydrated, and coverslipped in Histomount (National Diagnostics, Atlanta, GA, USA).
METHODS
Antibodies utilized to detect specific proteins or cell Breeding types are listed in Table 1 . The specificity of each antiBreeding, and genotyping of the TSLP transgenic mouse body clone has been established as referenced. For all strain has previously been described in detail [21] . The samples, negative controls for the immunohistochemisstudy was performed after backcrossing to a C57BL6 try included substituting for the primary antibody an background for more than eight generations. Male TSLP irrelevant IgG from the same species or phosphate-buftransgenic mice were than mated with wild type C57BL6 fered saline (PBS). females. The procedures used were approved by the local All slides were scored by an observer who was blinded Animal Care Committee of the University of Washington.
to the origin of the histologic specimen. Semiquantitative scoring of glomerular expression of ␣SMA, type I and Experimental design IV collagen, and laminin was performed using five grades A total of 123 mice including 61 TSLP transgenic mice as follows: 0 ϭ absent staining; 1 ϭ mesangial staining and 62 wild-type controls were used. Male mice were involving less than 25% of the area examined; 2 ϭ segsacrificed at monthly intervals up to seven months of age mental mesangial staining involving 25 to 50% of mesan-(N ϭ 75), female mice were sacrificed at 1, 1.5, 2, 2.5 gial areas present; 3 ϭ mesangial staining involving 50 months of age (N ϭ 48).
to 75% of the areas examined; and 4 ϭ diffuse mesangial These mice have been evaluated by immunohistostaining involving more than 75% of areas examined as chemistry for ␣SMA, collagen type I, collagen type IV, previously described and illustrated [22] . The number of and laminin. Expression of PDGF-B chain, PDGF ␤-R, PCNA positive cells in the glomerular tufts was counted TGF-␤1 mRNA expression were evaluated by in situ at a magnification of ϫ400. Both the number of the hybridization. Additionally, a preliminary series of 27 intraglomerular positive cells and the number of glomer-TSLP transgenic and 16 wild-type controls were evaluuli were counted and the data were presented as posiated for PDGF-A chain and PDGF ␣-R, PDGF-B chain, tively stained cells per glomerular cross section (gcs). PDGF-␤-R, TGF-␤1 mRNA by in situ hybridization.
Cells outside the glomerular tufts were not included. At Renal morphology least 20 consecutive cross sections of glomeruli were examined using each of the above antibodies. The morRenal tissue was fixed in part in 10% neutral-buffered phometric analysis of glomerular cell numbers has been formalin and in methyl Carnoy's solution as described described previously [21] . previously [22] . Fixed tissues were processed, embedded in paraffin according to standard protocols and sectioned Molecular probes at 4 m. Slides were stained with periodic acid methenaThe molecular probes used in this study have premine silver (silver), with periodic acid-Schiff's (PAS), and viously been described and used for in situ hybridization hematoxylin and eosin (H&E) using standard histologic procedures. [30] . These included probes for: [25] muscle actin (DAKO, Carpinteria, CA, USA) rat anti-mouse IgG2a (Caltag Laboratories) Type I collagen [26] Goat polyclonal antibody anti-human collagen I Biotinylated rabbit anti-goat 1:1000 (Southern Biotechnology, Birmingham, AL, USA) IgG (Vector Laboratories, Burlingame, CA, USA) Type IV collagen [27] Goat polyclonal antibody anti-human collagen IV Biotinylated rabbit anti-goat 1:600 (Southern Biotechnology) IgG (Vector Laboratories) Laminin [28] Rabbit polyclonal antibody anti-rat laminin (mouse Biotinylated goat anti-rabbit 1:800 cross react) (Chemicon, Temecula, CA, USA) IgG (Vector Laboratories) Mac-2 [29] M3/38 Rat IgG monoclonal antibody anti-mouse Mac-2 Biotinylated goat anti-mouse 1:5000 (CEDARLANE, Hornby, Ontario, Canada)
IgG, mouse adsorbed (Vector Laboratories)
All antigens were immunostained using methyl Carnoy's fixed tissue, except PCNA and Mac-2 on formalin fixed tissue. 
Fig. 2. Immunohistochemical staining for extracellular membrane (ECM). (A-D) Immunohistochemistry for type IV collagen (A, B)
and laminin (C, D) in a wild-type control (A, C) and a TSLP transgenic female at the age of 2.5 months (B, D; all original magnification ϫ400). TSLP transgenic mice demonstrated an increase in collagen IV and laminin in a mesangial pattern as compared to wild type controls. (E-H ) Immunohistochemistry for type IV collagen (F), and laminin (H) and silver stains (E, G) performed on serial sections of a TSLP male at the age of 5 months (all orig. ϫ400). The widening of the mesangial matrix in this case was mainly due to massive immune deposits, which are silver negative and do not stain for type IV collagen and laminin. Note the positive staining in the remaining mesangial matrix.
PDGF-A chain: A 536 nucleotides (nt) SmaI fragment PDGF ␣-R:
A 1636 nt EcoRI fragment of the mouse cDNA (GenBank Acc. #M57683: nt 201 to 1837) of the mouse PDGF A-chain cDNA (GenBank Acc.
was cloned into the EcoRI site of pGEM-3Zfϩ #M29464: nt 1 to 906) was cloned into the SmaI (Promega Biotec). The full-length probe is 1692 nt. site of pGEM-3Zfϩ (Promega Biotec, Madison, WI, USA). The full-length probe is 592 nt.
PDGF ␤-R: A 2075 bp PstI fragment of the mouse cDNA (GenBank Acc. #X04367: nt 1667 to 3742) PDGF-B chain: An 806 nt EcoRI fragment of the was inserted into the PstI site of pGEM-3Zfϩ (Promouse cDNA that contains a 752 nt fragment of mega Biotec). The full-length probe is 2131 nt. mouse B-chain was a gift from C. Stiles (DanaFarber Cancer Institute, Boston, MA, USA). It was TGF-␤1: (gift from H.L. Moses, Dept. Cell Biology, inserted into the EcoRI site of pGEM-3Zfϩ (ProVanderbilt University, Nashville, TN, USA) [31] . A mega Biotec). The full-length probe encodes for the 974 nt fragment of the mouse cDNA was inserted into the SmaI site of pGem7Zfϩ (Promega Biotec). whole PDGF B-chain molecule. After linearization 35 S antisense and sense (negative con-␤-R, or TGF-␤1), combined immunohistochemistry and trol) riboprobes were produced, using reagents from Proin situ hybridization were performed as previously demega, and 35 S UTP, from NEN (Boston, MA, USA) [32] .
scribed [33] . Slides were first hybridized with antisense and sense riboprobes for detection of TGF-␤1, PDGF-B In situ hybridization chain or PDGF-␤-R mRNA. After stringency washes, The in situ hybridization protocols have recently been slides were immunostained for macrophages (Mac-2) described in detail [33, 34] . Negative controls included using the DAB detection system without nickel chloride hybridization performed on replicate tissue sections usenhancement to produce a brown reaction product. Foling the sense riboprobe.
lowing immunostaining, slides were washed, dehydrated The intensity of intraglomerular expression for each and dipped in NTB-2 emulsion. transcription was graded semiquantitatively by an observer blinded to origin of the histologic specimen as Statistical analysis follows: 0 ϭ absent, 1 ϭ mild (a few positive cells), 2 ϭ All values are expressed as the mean Ϯ standard deviamoderate (several positive cells in a segmental distribution (SD). Using the SPSS program, Version 10.0 for tion within the glomerulus), and 3 ϭ severe (many posiWindows (SPSS Inc., Chicago, IL, USA), the non-parative cells in a diffuse distribution).
metric Mann-Whitney U-test was used to compare the Combined immunohistochemistry and in situ hybridization means between groups. The number of macrophages expressing PDGF-B chain or TGF-␤1 mRNA was comTo identify monocyte/macrophage expression of specific growth factors and receptors (PDGF B-chain, PDGFpared for each of the study time points by one-way analy-study [21] . Renal lesions were characterized by mesangial expansion due to matrix and immune complex deposition, thickened and split capillary walls with prominent immune deposits and cellular interposition and macrophage influx, which are typical features of cryoglobulinemic MPGN. All TSLP transgenic mice demonstrated a widening of the mesangial area after the age of one month, which was more prominent in female than in males at early time points. Massive deposition of immune complexes were present also in the capillary walls of both genders of transgenic mice, which sometimes led to complete capillary occlusion with progression of the disease. In the most severe cases, the mesangium was expanded and most of the capillary lumina were occluded. In contrast, globally sclerotic glomeruli were not found in either gender of transgenic mice even at late time points. The progression of renal lesion and the disease course were more pronounced and more accelerated in female than in male mice.
Glomerular expression of ␣-smooth muscle actin is increased in TSLP transgenic mice ␣-Smooth muscle actin is expressed by smooth muscle cells of the arterial wall in normal kidneys, as well as by mesangial cells during renal development, and by activated mesangial cells during glomerular injury [22] . All renal specimens from TSLP transgenic mice and controls demonstrated intense staining for ␣SMA by smooth muscle cells in arterial walls in the interstitium. In most controls ␣SMA staining was restricted to these sites (Fig. 1A) . However, a few glomeruli in control animals demonstrated mesangial ␣SMA expression, usually in a segmental distribution within the glomerular tuft. In contrast, TSLP transgenic mice of both genders exhibited increased ␣SMA expression in a mesangial pattern beginning at the age of one month. Female TSLP transgenic mice demonstrated a constant increase of ␣SMA protein expression through the course of the disease (0.9 Ϯ 0.2 0.1 in controls, P Ͻ 0.05), and then gradually decreased Additionally, the non-parametric Spearman rank corre- (Fig. 1D) . At the age of one month female mice demonlation coefficients was used to determine the association strated higher scores than male mice. No apparent between PDGF mRNA score and the number of glomer-␣SMA expression was observed in interstitial cells of ular proliferating cells among each group.
TSLP transgenic mice as well as of control mice, and tubular epithelium was negative in the well preserved tubulointerstitium. RESULTS
Morphology
Deposition of extracellular matrix is associated with increased type IV collagen and laminin protein Glomerular pathologic alterations of TSLP transgenic expression in TSLP transgenic mice mice during the time course of the study, which covers first 2.5 months of age in female and the first seven
The area and percentage of glomerular ECM was assessed by morphometric analysis on silver methenamine months of age in males, were described in a previous stained sections [21] . An increased deposition of extracellular matrix was demonstrated early in the disease course and reached a plateau in both genders [21] . To assess the sequential contribution of individual ECM components, immunohistochemical staining was performed for type I collagen, type IV collagen and laminin. Control mice of both genders demonstrated immunostaining of type IV collagen in the glomerular and tubular basement membranes. Glomerular staining for type IV collagen in control mice was focal in distribution, which had no apparent change during the ages studied ( Figs.  2A and 3 A, B) . A similar staining pattern for laminin was observed in control kidneys (Figs. 2C and 3 C, D) . In contrast, TSLP transgenic mice demonstrated increased staining for type IV collagen and laminin predominantly in the mesangium (Fig. 2 B, D, F, H) . In the most severe cases, the mesangium was widened due to both matrix accumulation and massive deposition of immune deposits, at times associated with complete capillary occlusion [21] . Although the expanded mesangial area in transgenic mice was due to increased matrix deposition, this did not advance to global sclerosis, as such glomeruli were absent throughout the time course of the disease that was studied [21] . Areas occupied by immune deposits, as determined by correlative electron microscopy, did not stain with the silver methenamine reagent, and these areas also were unreactive with antibodies to detect both collagen type IV and laminin accumulation ( merulus was demonstrated in TSLP transgenic mice, the 1.9 Ϯ 0.1 in controls, P Ͻ 0.01; Fig. 3B ; laminin, 2.7 Ϯ total cell number per glomerulus was increased signifi-0.1 in TSLP transgenic mice vs. 0.6 Ϯ 0.3 in controls, cantly in TSLP transgenic mice [21] . Therefore, we as-P Ͻ 0.05; Fig. 3D ). Glomerular staining for collagen I sessed the percentage of PCNA-positive cells with rewas absent in both controls and TSLP transgenic mice spect to the total glomerular cell number. The proportion (data not shown).
of PCNA-positive cells compared to the total glomerular cells in female transgenic mice increased progressively An increased number of proliferating glomerular cells to month 2.5 (5.5 Ϯ 2.1% in month 1, 13.3 Ϯ 5.2% in characterizes the increased glomerular cellularity in month 2.5). Male transgenic mice had a gradual increase TSLP transgenic mice in percentage of proliferative cells up to month 7 (3.3 Ϯ A significant increase in PCNA positive cells was dem-1.3% in month 1, 7.8 Ϯ 4.3% in month 7). In contrast, onstrated beginning at month 1 in both genders of TSLP the proportion of PCNA-positive cells per glomerulus transgenic mice, and was more pronounced in females did not change in control groups. at this time point (Fig. 4) . In male TSLP transgenic mice, PDGF-B chain and PDGF-␤-R mRNA is increased in glomerular cell proliferation reached a plateau at three TSLP transgenic mice and correlates with glomerular months of age (3.4 Ϯ 1.3 PCNA positive cells/gcs vs. cell proliferation 0.3 Ϯ 0.2 in controls, P Ͻ 0.05), while female transgenic mice had a gradual elevation up to month 2.5 (6.2 Ϯ 2 Representative in situ hybridization results including sense controls are illustrated in Figure 5 and Figure 6 . PCNA positive cells/gcs vs. 0.3 Ϯ 0.1 in controls, P Ͻ A preliminary series of animals (Methods section) was scattered tubulointerstitial cells both in wild-type and TSLP transgenic mice without apparent differences bestudied by in situ hybridization for expression of PDGF A-chain, PDGF-B chain and their receptors, PDGF-␣-R tween the two groups. As shown in Figure 7 , the glomerular expression patterns of PDGF-B chain and PDGF-␤-R and ␤-R. Glomerular expression of PDGF A-chain was not detected and PDGF-␣-R was present in a very low mRNA in controls did not significantly vary over time between the two genders. In contrast, the expression of number of glomeruli, whereas a prominent induction of PDGF-B chain and PDGF-␤-R became apparent. There-PDGF-B chain or PDGF-␤-R mRNA reached a plateau after three months of age in TSLP transgenic males fore, these two factors were chosen for further study in the current prospective animal series.
( Fig. 7 B, D) , whereas female mice demonstrated high expression for each probe as early as the first month of Glomeruli of wild-type controls showed either absent or weak mesangial expression of PDGF-B chain (Fig. age and this remained elevated for the duration of time course of the study (Fig. 7 A, C) . In TSLP transgenic 5 A, C) and PDGF ␤-R mRNA (Fig. 6 A, C) . In contrast, TSLP transgenic mice exhibited increased expression of mice, there was a moderate to strong positive correlation between the number of glomerular proliferating cells PDGF-B chain and PDGF ␤-R in both the mesangium and the parietal epithelial cells (Fig. 5 B, D) . Expression and the intensity of glomerular expression for PDGF B-chain (Spearman r ϭ 0.63, P ϭ 0.002 for females; of PDGF-B chain and PDGF ␤-R mRNA was found in Fig. 8B ) expression, they did not manifest a significant glomerular proliferative response (Fig. 8) . or PDGF-␤-R mRNA (Spearman r ϭ 0.70, P Ͻ 0.001 for females; Fig. 8C , Spearman r ϭ 0.75, P Ͻ 0.001 for TGF-␤1 mRNA is increased in TSLP transgenic mice males; Fig. 8D ). In contrast, the association between those variables in control groups was very weak (PDGF As TGF-␤1 is thought to be of major importance during the deposition of ECM, the expression of TGF-␤1 B-chain, Spearman r ϭ 0.23, P ϭ 0.31 for females, Fig. 8A , and Spearman r ϭ Ϫ0.05, P ϭ 0.76 for males; mRNA was studied by in situ hybridization. Weak expression of TGF-␤1 mRNA in a mesangial pattern was Fig. 8B ; PDGF-␤-R, Spearman r ϭ Ϫ0.18, P ϭ 0.42 for females, Fig. 8C , and Spearman r ϭ 0.16, P ϭ 0.37 for detected in control mice (Fig. 9 A, C) . Female transgenic mice showed increased glomerular expression of TGF-␤1 males; Fig. 8D) . Although a few control mice showed elevated levels of PDGF-B chain and PDGF-␤-R mRNA mRNA beginning at the age of 1.5 months (Figs. 9B and Fig. 9 . In situ hybridization for TGF-␤1 mRNA. In situ hybridization using a TGF-␤1 antisense riboprobe (A-D) and a sense riboprobe control (E ) performed on tissue sections from wild-type controls (A, female; C, male) and a 2.5-month-old TSLP transgenic female (B) and a TSLP transgenic male at the age of 6 months (D, all orig. ϫ400). Only a weak signal is present in wild-type controls, while there is prominent up-regulated expression of TGF-␤1 in TSLP transgenic mice. Minimal background accumulation of silver grains is present in E.
10A). In contrast, TSLP transgenic males demonstrated chain mRNA was expressed by intrinsic renal cells an increased expression beginning at four months up to that did not express the macrophage marker (Fig. 11A ). seven months of age (Figs. 9D and 10B ), but did not show Macrophages expressing PDGF-␤-R mRNA were not significant changes from the normal expression pattern detected in any of the transgenic mice (Fig. 11B) . Figure  prior to month 3.
12 shows the percentage of the glomerular macrophages that express these growth factors at the different time Intraglomerular macrophages express PDGF-B chain points studied. The proportion of glomerular macroand TGF-␤1 mRNA but not PDGF-␤-R mRNA phages expressing PDGF-B chain and TGF-␤1 mRNA To identify glomerular monocytes/macrophages as a did not show significant differences when analyzed at potential source of growth factors or the PDGF ␤ recepdifferent time points. tor, we combined immunohistochemical labeling of Mac-2 expressing macrophages with in situ hybridization for PDGF-B chain, PDGF-␤-R, and TGF-␤1 mRNA. Renal DISCUSSION tissues obtained from control TSLP wild-type mice were
A new transgenic mouse model of cryoglobulinemic not included in this part of the study, because glomerular MPGN gave us the opportunity to describe the temporal macrophages in wild-type mice were barely detected in changes in expression of several members of the PDGF previous experiments [21] .
family and TGF-␤1, in combination with components of A significant proportion (approximately half) of intrathe ECM and markers of cell activation/proliferation, in glomerular monocytes/macrophages manifesting Mac-2 this disease process [21] . The glomerular lesion in TSLP antigen expressed TGF-␤1 mRNA (Figs. 11C and Fig. 12) . transgenic mice is characterized by widening of the mesIn contrast, only a small percentage (less than 10%) of angium due to an expanded mesangial matrix and depoglomerular Mac-2 expressing monocytes/macrophages sition of immune deposits, increased glomerular size with expressed PDGF B-chain mRNA during any of the time points studied (Figs. 11A and 12) . Most of the PDGF-B an increase of the absolute glomerular cell number, sub-whereas collagen type I was not detectable. These results are consistent with data in human MPGN, which describe increased expression type IV collagen and laminin in the glomerular mesangial areas and the peripheral capillary walls [36, 37] . In contrast to the rare occurrence or absence to the expression of PDGF-A chain and PDGF-␣-R, as revealed by our pilot studies, there is prominent induction of PDGF-B chain and the corresponding receptor PDGF-␤-R in this disease model. The distribution patterns for this ligand/receptor pair were very similar in mesangial areas, and parietal epithelial cells. PDGF-B chain and ␤-R correlated significantly with the number of proliferating glomerular cells. Up-regulation of PDGF protein previously has shown to correlate with glomerular mesangial cell proliferation [38] [39] [40] . Additionally, the expression of PDGF-B chain and ␤-R paralleled an increase in extracellular matrix. The importance of PDGF-B chain in the regulation of glomerular extracellular matrix accumulation, as well as in mesangial cell proliferation has been demonstrated by several interventional studies [9, 15, 41] . Experiments with infusion of PDGF-B chain in the anti-Thy1.1 model in rats [41] or transfection of PDGF-B chain cDNA to rats [15] induced selective glomerular mesangial cell proliferation and matrix accumulation redundant [8, 15] . Furthermore, blockade by a neutralizing antibody to PDGF reduced mesangial cell proliferation and largely prevented the increased deposition extracellular matrix in anti-Thy1.1 glomerulonephritis [9] . Here we demonstrate the expression of PDGF-B chain and its receptor in a mouse model with a membra- tion. Induction of PDGF-B chain was demonstrated earlier in females as compared to males, consistent with more severe lesions that occur in females at earlier time points. endothelial immune deposits in peripheral capillary walls, Transforming growth factor-␤ also has been shown to and splitting of capillary basement membranes.
play an important role during the development of mesWe documented that a change in the mesangial cell angial matrix expansion [16, 19] . Increased expression phenotype characterized by de novo expression of ␣SMA of TGF-␤1 has been reported in several experimental was found early in the disease course in both genders of models as well as in human glomerulonephritis [42] [43] [44] [45] [46] [47] [48] . TSLP transgenic mice and showed a progressive increase One study suggested a potential role for direct stimulain TSLP transgenic males. This phenotypic change has tion of glomerular cells by immune complexes composed previously been described in other rodent models of reof IgG and IgA, which then trigger the formation of ECM nal injury [8, 25, 35] , and in human glomerulonephritis via Fc receptors, utilizing pathways involving TGF-␤1 including MPGN [22] . In TSLP transgenic mice this change [49] . The actual stimulus for TGF-␤1 production in our is likely related to activation of mesangial cells following model or in human disease is not yet known. It is clear deposition of immune complexes.
that the time course of TGF-␤1 mRNA paralleled the exAn increase of extracellular mesangial matrix develpression of extracellular matrix proteins in our model, ops early in the development of the disease in TSLP transconsistent with established paradigms. genic mice, but does not progress to global glomeruloOur study also established that the intraglomerular sclerosis, at least within the time frame studied. Here monocytes/macrophages may be a source for some of the we demonstrated that this matrix accumulation is due PDGF-B chain and TGF-␤1 activity in the glomerular injury. TSLP transgenic mice develop significant monoin part to deposition of collagen type IV, and laminin, cyte/macrophage infiltration in glomeruli [21] . Although ity of cells producing PDGF-B chain were mesangial cells [40] . monocytes/macrophage are known to be one of the maBased on the above, these are several principal points jor sources of growth factors including PDGF and TGF-␤ to be gleaned from this study. First, the findings demon-[50, 51], the contribution of infiltrating macrophages strating expression and presumptive activities of PDGF-B compared with that of renal intrinsic cells in the synthesis chain and its receptor and TGF-␤1 in this model of of growth factors currently has not been established. In MPGN conform to paradigms established in the rat our model, a significant proportion of Mac-2 expressing model of anti-Thy1 of mesangiolytic injury and repair. monocytes/macrophages expressed TGF-␤1, which sugWe believe this is important because it demonstrates gests increased TGF-␤1 activity may be the result of both that these paradigms are generalizable to glomerular paracrine secretion and autocrine production in this and mesangial injuries other than mesangiolysis, and to model. In contrast, the percentage of monocytes/macrospecies other than the rat. The close morphologic similarphages expressing PDGF B-chain was small in TSLP ity between renal injury in the TSLP transgenic mouse transgenic mice, and it is it unlikely that they are the and human cryoglobulinemic MPGN means it is likely, major source of increased glomerular PDGF. Previous
though not yet proven, that similar expression of these studies demonstrated that in the rat anti-Thy1.1 model growth factors occurs at similar stages of injury in the of mesangial proliferative glomerulonephritis, more than human disease. The predictable injury course in these 90% of the glomerular cells immunostaining for PDGF mice, which occurs notably early in female mice, suggests it would serve as a good model system to test interven-B-chain also expressed ␣SMA, indicating that the major- 
